Two sectors that the bears love to hate are biotech and homebuilders. The "bubble" in biotech has been called out numerous times over the last few years, while the housing rebound is supposedly a "sucker's rally," according to the naysayers.
The argument against biotech stocks has focused on the valuations of the stocks. While this argument may be true for the smaller, money-losing stocks in the sector, the large-cap names are trading at valuations more attractive than the overall market.
The homebuilder bears will concentrate their argument that the U.S. economy is not on stable ground, and that first-time homebuyers are not coming back into the market.
Last month, 29 percent of home purchases were first-time buyers, the first ...
/www.benzinga.com/general/biotech/15/03/5372203/these-2-hated-etfs-have-outperformed-the-market alt=These 2 Hated ETFs Have Outperformed The Market>Full story available on Benzinga.com
More...